Article info
PDFTherapeutics
Systematic review and meta-analysis
Dual antiplatelet therapy in recurrent stroke prevention: do the benefits outweigh the risks?
- Correspondence to: Dr Muhammad U Farooq, Section of Vascular Neurology and Stroke, Hauenstein Neuroscience Center, 220 Cherry Street SE, Grand Rapids, Michigan 49503, USA; farooqmu{at}mercyhealth.com
Citation
Dual antiplatelet therapy in recurrent stroke prevention: do the benefits outweigh the risks?
Publication history
- First published February 11, 2014.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions